|
MPDZ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62914126633495E-12 |
| Normal-vs-Stage2 |
3.41300000039624E-07 |
| Normal-vs-Stage3 |
1.41669999953464E-07 |
| Normal-vs-Stage4 |
1.76819999975208E-07 |
| Stage1-vs-Stage2 |
6.899200E-01 |
| Stage1-vs-Stage3 |
3.746800E-01 |
| Stage1-vs-Stage4 |
1.956430E-01 |
| Stage2-vs-Stage3 |
7.538000E-01 |
| Stage2-vs-Stage4 |
1.573580E-01 |
| Stage3-vs-Stage4 |
9.192400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62503344114384E-12 |
| Normal-vs-AfricanAmerican |
4.2819081613743E-12 |
| Normal-vs-Asian |
5.625000E-04 |
| Caucasian-vs-AfricanAmerican |
6.605800E-01 |
| Caucasian-vs-Asian |
6.589000E-01 |
| AfricanAmerican-vs-Asian |
7.795600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
6.95690000052096E-07 |
| Male-vs-Female |
9.524700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.46119996289474E-09 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.55040003058105E-09 |
| Normal-vs-Extreme_Obese |
1.90919999999428E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.239600E-01 |
| Normal_Weight-vs-Obese |
9.483200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.587800E-01 |
| Extreme_Weight-vs-Obese |
1.465820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.074200E-01 |
| Obese-vs-Extreme_Obese |
9.084600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.824999999542E-08 |
| Normal-vs-Age(41-60Yrs) |
1.45290002251386E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.3030000000368E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.109200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.925800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.981800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.028200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.555000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.965400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.36060004876748E-09 |
| Normal-VS-KIRP CIMP |
2.75580000042019E-07 |
| Normal-VS-Unclassified PRCC |
7.67629999565145E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.954400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.982200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.987200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.256030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.496400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.551700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74480471474226E-11 |
| Normal-vs-N1 |
3.46059958467038E-10 |
| Normal-vs-N2 |
7.356500E-04 |
| N0-vs-N1 |
6.939400E-01 |
| N0-vs-N2 |
7.201800E-01 |
| N1-vs-N2 |
7.969800E-01 |
|
|
